Oncology

Myelodysplastic Syndrome & Acute Myeloid Leukemia

Advertisment
Emerging Immuno-Myeloid Therapies in MDS and AML
Myelodysplastic Syndrome & Acute Myeloid Leukemia

Emerging Immuno-Myeloid Therapies in MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Improving Response Durability in High-Risk MDS and AML
Myelodysplastic Syndrome & Acute Myeloid Leukemia

Improving Response Durability in High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Integrating Genomics Into the Classification and Management of MDS
Myelodysplastic Syndrome & Acute Myeloid Leukemia

Integrating Genomics Into the Classification and Management of MDS

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML
Myelodysplastic Syndrome & Acute Myeloid Leukemia

Promising Lower-Intensity Regimens for Patients With High-Risk MDS and AML

expert roundtables
By Andrew M. Brunner, MD; Courtney D. DiNardo, MD, MSCE; Rami S. Komrokji, MD
Relapsed AML: Past, Present, and Future
Myelodysplastic Syndrome & Acute Myeloid Leukemia

Relapsed AML: Past, Present, and Future

patient care perspectives
By Courtney D. DiNardo, MD, MSCE
Load More   

Experts in Myelodysplastic Syndrome & Acute Myeloid Leukemia

+3

Meet the Experts   

Advertisment